Cingulate (CING) vs Spero Therapeutics (SPRO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cingulate (CING) has outperformed Spero Therapeutics (SPRO) over the past year, gaining 17.3% versus a loss of 45.8%. Cingulate is the larger company by market cap ($70.8 million vs $68.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CING | SPRO |
|---|---|---|
| Share price | $4.87 | $1.17 |
| Market cap | $70.82M | $68.13M |
| 1-day change | -0.41% | -1.68% |
| YTD return | +12.21% | -49.79% |
| 1-year return | +17.35% | -45.83% |
| 5-year return | — | -93.13% |
| P/E ratio (TTM) | — | 8.36 |
| EPS (TTM) | $-3.51 | $0.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.89 | $3.08 |
| 52-week low | $3.16 | $1.08 |
| Distance from 52-week high | -59.04% | -62.01% |
| Average volume | 150.39K | 1.21M |
| Shares outstanding | 14.54M | 58.23M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CING has outperformed SPRO by 63.2 percentage points over the past year.
CING vs SPRO FAQ
Which is bigger, Cingulate or Spero Therapeutics?
Cingulate (CING) is larger, with a market capitalization of $70.82M compared with $68.13M for Spero Therapeutics (SPRO).
Which stock has performed better over the past year, CING or SPRO?
CING returned +17.35% over the past 12 months, compared with -45.83% for SPRO (price return, excluding dividends). Past performance does not predict future results.
Are Cingulate and Spero Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.